|
BI 6015,肝细胞核因子4α(HNF4α)拮抗剂
|
B287789-50mg
|
Moligand™, ≥98%(HPLC) |
93987-29-2 |
50mg
|
¥ 689.9
|
现货 |
|
0 |
阿拉丁 |
|
BI 6015,肝细胞核因子4α(HNF4α)拮抗剂
|
B287789-10mg
|
Moligand™, ≥98%(HPLC) |
93987-29-2 |
10mg
|
¥ 250.9
|
现货 |
|
0 |
阿拉丁 |
|
BAY 87-2243,线粒体复合物I抑制剂
|
B287776-5mg
|
≥98%(HPLC) |
1227158-85-1 |
5mg
|
¥ 601.9
|
现货 |
|
0 |
阿拉丁 |
|
BAY 87-2243,线粒体复合物I抑制剂
|
B287776-25mg
|
≥98%(HPLC) |
1227158-85-1 |
25mg
|
¥ 2574.9
|
现货 |
|
0 |
阿拉丁 |
|
BMS 453,合成类维生素A和RARβ激动剂
|
B287683-10mg
|
≥98%(HPLC) |
166977-43-1 |
10mg
|
¥ 1699.9
|
现货 |
|
0 |
阿拉丁 |
|
BAY 677
|
B287674-5mg
|
≥98% |
2117404-84-7 |
5mg
|
¥ 699.9
|
现货 |
|
0 |
阿拉丁 |
|
BAY 677
|
B287674-25mg
|
≥98% |
2117404-84-7 |
25mg
|
¥ 2399.9
|
现货 |
|
0 |
阿拉丁 |
|
BP 554 马来酸盐
|
B287672-50mg
|
≥99%(HPLC) |
1221401-95-1 |
50mg
|
¥ 4226.9
|
现货 |
|
0 |
阿拉丁 |
|
BP 554 马来酸盐
|
B287672-10mg
|
≥99%(HPLC) |
1221401-95-1 |
10mg
|
¥ 1168.9
|
现货 |
|
0 |
阿拉丁 |
|
BRD 4770,G9a抑制剂和S-腺苷甲硫氨酸类似物
|
B287662-50mg
|
Moligand™, ≥98%(HPLC) |
1374601-40-7 |
50mg
|
¥ 2678.9
|
现货 |
|
0 |
阿拉丁 |
|
BRD 4770,G9a抑制剂和S-腺苷甲硫氨酸类似物
|
B287662-10mg
|
Moligand™, ≥98%(HPLC) |
1374601-40-7 |
10mg
|
¥ 833.9
|
现货 |
|
0 |
阿拉丁 |
|
2B-(SP) (TFA)
|
B287641-1mg
|
≥95% |
186901-17-7 |
1mg
|
¥ 799.9
|
现货 |
|
0 |
阿拉丁 |
|
BIRT 377,LFA-1的强负变构调节剂
|
B287562-50mg
|
Moligand™, ≥98%(HPLC) |
213211-10-0 |
50mg
|
¥ 9499.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
BIRT 377,LFA-1的强负变构调节剂
|
B287562-10mg
|
Moligand™, ≥98%(HPLC) |
213211-10-0 |
10mg
|
¥ 2339.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
6-Bnz-cAMP钠盐
|
B287513-1mg
|
≥98%(HPLC) |
1135306-29-4 |
1mg
|
¥ 1669.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Bifemelane hydrochloride,MAO抑制剂
|
B287497-50mg
|
≥99%(HPLC) |
62232-46-6 |
50mg
|
¥ 1269.9
|
现货 |
|
0 |
阿拉丁 |
|
Bifemelane hydrochloride,MAO抑制剂
|
B287497-10mg
|
≥99%(HPLC) |
62232-46-6 |
10mg
|
¥ 437.9
|
现货 |
|
0 |
阿拉丁 |
|
布列奎钠
|
B287474-50mg
|
≥98% |
96201-88-6 |
50mg
|
¥ 2594.9
|
现货 |
|
0 |
阿拉丁 |
|
布列奎钠
|
B287474-10mg
|
≥98% |
96201-88-6 |
10mg
|
¥ 720.9
|
现货 |
|
0 |
阿拉丁 |
|
BMS CCR2 22(CCR2拮抗剂)
|
B287471-50mg
|
≥98%(HPLC) |
445479-97-0 |
50mg
|
¥ 8699.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
BMS CCR2 22(CCR2拮抗剂)
|
B287471-1mg
|
≥98%(HPLC) |
445479-97-0 |
1mg
|
¥ 899.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
BMS CCR2 22(CCR2拮抗剂)
|
B287471-10mg
|
≥98%(HPLC) |
445479-97-0 |
10mg
|
¥ 4409.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
BRACO 19 三盐酸盐
|
B287457-50mg
|
≥95%(HPLC) |
1177798-88-7 |
50mg
|
¥ 5799.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
BRACO 19 三盐酸盐
|
B287457-10mg
|
≥95%(HPLC) |
1177798-88-7 |
10mg
|
¥ 1899.9
|
期货,请咨询 |
|
0 |
阿拉丁 |